266 related articles for article (PubMed ID: 24486364)
1. Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR.
Pasinato A; Indolfi G; Marchisio P; Valleriani C; Cortimiglia M; Spanevello V; Chiamenti G; Buzzetti R; Resti M; Azzari C;
Vaccine; 2014 Mar; 32(12):1375-81. PubMed ID: 24486364
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.
Nunes MC; Jones SA; Groome MJ; Kuwanda L; Van Niekerk N; von Gottberg A; de Gouveia L; Adrian PV; Madhi SA
Vaccine; 2015 Jan; 33(5):628-34. PubMed ID: 25541213
[TBL] [Abstract][Full Text] [Related]
3. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
[TBL] [Abstract][Full Text] [Related]
4. Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy.
Ansaldi F; de Florentiis D; Canepa P; Zancolli M; Martini M; Orsi A; Durando P; Icardi G
Vaccine; 2012 Mar; 30(13):2288-94. PubMed ID: 22306795
[TBL] [Abstract][Full Text] [Related]
5. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J
Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440
[TBL] [Abstract][Full Text] [Related]
6. Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada.
Kellner JD; Scheifele D; Vanderkooi OG; Macdonald J; Church DL; Tyrrell GJ
Pediatr Infect Dis J; 2008 Jun; 27(6):526-32. PubMed ID: 18458650
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.
Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH
Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E
Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717
[TBL] [Abstract][Full Text] [Related]
9. Carriage of Haemophilus influenzae is associated with pneumococcal vaccination in Italian children.
Camilli R; Vescio MF; Giufrè M; Daprai L; Garlaschi ML; Cerquetti M; Pantosti A
Vaccine; 2015 Aug; 33(36):4559-64. PubMed ID: 26190092
[TBL] [Abstract][Full Text] [Related]
10. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.
Cohen R; Levy C; Bingen E; Koskas M; Nave I; Varon E
Pediatr Infect Dis J; 2012 Mar; 31(3):297-301. PubMed ID: 22330166
[TBL] [Abstract][Full Text] [Related]
11. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric radiologically confirmed community acquired pneumonia following PCV7 introduction in Switzerland.
Chappuy H; Keitel K; Gehri M; Tabin R; Robitaille L; Raymond F; Corbeil J; Maspoli V; Bouazza N; Alcoba G; Lacroix L; Manzano S; Galetto-Lacour A; Gervaix A
BMC Infect Dis; 2013 Jul; 13():357. PubMed ID: 23899390
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece.
Grivea IN; Priftis KN; Giotas A; Kotzia D; Tsantouli AG; Douros K; Michoula AN; Syrogiannopoulos GA
Vaccine; 2014 Nov; 32(48):6513-20. PubMed ID: 25252194
[TBL] [Abstract][Full Text] [Related]
14. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
[TBL] [Abstract][Full Text] [Related]
15. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.
Dagan R; Givon-Lavi N; Porat N; Greenberg D
Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece.
Grivea IN; Tsantouli AG; Michoula AN; Syrogiannopoulos GA
Vaccine; 2011 Nov; 29(48):8882-7. PubMed ID: 21963873
[TBL] [Abstract][Full Text] [Related]
17. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
18. Changes in nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among healthy children attending a day-care centre before and after official financial support for the 7-valent pneumococcal conjugate vaccine and H. influenzae type b vaccine in Japan.
Oikawa J; Ishiwada N; Takahashi Y; Hishiki H; Nagasawa K; Takahashi S; Watanabe M; Chang B; Kohno Y
J Infect Chemother; 2014 Feb; 20(2):146-9. PubMed ID: 24582389
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
Dagan R; Patterson S; Juergens C; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
Clin Infect Dis; 2013 Oct; 57(7):952-62. PubMed ID: 23804191
[TBL] [Abstract][Full Text] [Related]
20. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW
J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
